These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24053393)

  • 1. Perspectives on the role of surveillance in eliminating rubella and congenital rubella syndrome in the Americas.
    Andrus JK; de Quadros CA
    Expert Rev Vaccines; 2013 Sep; 12(9):989-93. PubMed ID: 24053393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles and rubella eradication in the Americas.
    Andrus JK; de Quadros CA; Solórzano CC; Periago MR; Henderson DA
    Vaccine; 2011 Dec; 29 Suppl 4():D91-6. PubMed ID: 22185837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening surveillance: confronting infectious diseases in developing countries.
    Andrus JK; Solorzano CC; de Oliveira L; Danovaro-Holliday MC; de Quadros CA
    Vaccine; 2011 Dec; 29 Suppl 4():D126-30. PubMed ID: 22188931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Global Elimination Of Measles And Rubella With Strengthening Of Health Systems In Developing Countries.
    Andrus JK; Cochi SL; Cooper LZ; Klein JD
    Health Aff (Millwood); 2016 Feb; 35(2):327-33. PubMed ID: 26858388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles elimination: progress, challenges and implications for rubella control.
    Cutts FT; Lessler J; Metcalf CJ
    Expert Rev Vaccines; 2013 Aug; 12(8):917-32. PubMed ID: 23984961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global landscape of measles and rubella surveillance.
    Patel MK; Gibson R; Cohen A; Dumolard L; Gacic-Dobo M
    Vaccine; 2018 Nov; 36(48):7385-7392. PubMed ID: 30318167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of rubella and congenital rubella syndrome--United States, 1969-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Mar; 54(11):279-82. PubMed ID: 15788995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(46):1048-50, 1059. PubMed ID: 11105768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1176-9. PubMed ID: 18971920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The principles and feasibility of disease eradication.
    Dowdle WR; Cochi SL
    Vaccine; 2011 Dec; 29 Suppl 4():D70-3. PubMed ID: 22188936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Measles and Rubella Laboratory Network, January 2004-June 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1100-4. PubMed ID: 16267497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efforts at rubella elimination in the United States: the impact of hemispheric rubella control.
    Dayan GH; Castillo-Solórzano C; Nava M; Hersh BS; Andrus J; Rodriguez R; Reef SE
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S158-63. PubMed ID: 16998776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward rubella elimination in Europe: an epidemiological assessment.
    Muscat M; Zimmerman L; Bacci S; Bang H; Glismann S; Mølbak K; Reef S;
    Vaccine; 2012 Mar; 30(11):1999-2007. PubMed ID: 22178098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virologic surveillance for wild-type rubella viruses in the Americas.
    Icenogle JP; Siqueira MM; Abernathy ES; Lemos XR; Fasce RA; Torres G; Reef SE
    J Infect Dis; 2011 Sep; 204 Suppl 2():S647-51. PubMed ID: 21954261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of congenital rubella and rubella infections in pregnancy in EU/EEA countries, 2012: Current status and future perspective to monitor elimination.
    Giambi C; Montaño-Remacha C; Celentano LP; Derrough T;
    Vaccine; 2015 Sep; 33(38):4929-37. PubMed ID: 26209837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global use of rubella vaccines, 1980-2009.
    Strebel PM; Gacic-Dobo M; Reef S; Cochi SL
    J Infect Dis; 2011 Sep; 204 Suppl 2():S579-84. PubMed ID: 21954250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.
    Mulders MN; Rota PA; Icenogle JP; Brown KE; Takeda M; Rey GJ; Ben Mamou MC; Dosseh AR; Byabamazima CR; Ahmed HJ; Pattamadilok S; Zhang Y; Gacic-Dobo M; Strebel PM; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):438-42. PubMed ID: 27148917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles and rubella elimination initiatives in the Americas: lessons learned and best practices.
    Castillo-Solorzano C; Marsigli C; Danovaro-Holliday MC; Ruiz-Matus C; Tambini G; Andrus JK
    J Infect Dis; 2011 Jul; 204 Suppl 1():S279-83. PubMed ID: 21666173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement.
    Reef SE; Cochi SL
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S123-5. PubMed ID: 16998770
    [No Abstract]   [Full Text] [Related]  

  • 20. Global measles elimination efforts: the significance of measles elimination in the United States.
    Strebel PM; Henao-Restrepo AM; Hoekstra E; Olive JM; Papania MJ; Cochi SL
    J Infect Dis; 2004 May; 189 Suppl 1():S251-7. PubMed ID: 15106119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.